# OnCo record gennao-bio (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/gennao-bio/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "gennao-bio" ;
  schema:name "Gennao Bio"@en ;
  schema:alternateName "Gennao"@en ;
  schema:description "Gennao Bio is a laboratory-stage company using an antibody licensed from Yale that can carry genetic material, or a cancer drug, into cells. Its cancer work so far is in animals."@en ;
  schema:url <https://onco.cc/companies/gennao-bio/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.biospace.com/gennao-bio-closes-40-million-series-a-financing-to-develop-pipeline-of-targeted-nucleic-acid-therapeutics>, <https://www.1stoncology.com/blog/?p=94931>, <https://www.orbimed.com/portfolio/> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/>, <https://onco.cc/fronts/adcs/> ;
  onco:technologies <https://onco.cc/technologies/adc/> .